032300 — Korea Pharma Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapFalling Star

Annual balance sheet for Korea Pharma Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	18,865	62,540	64,076	51,953	38,725
Net Total Accounts Receivable
Net Total Receivables	16,110	17,598	16,419	14,624	15,542
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	54,815	97,236	98,083	85,385	73,634
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	18,824	20,149	22,130	23,534	24,010
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	81,320	129,401	130,947	121,303	112,387
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	30,654	25,498	69,535	33,300	19,321
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	34,818	71,934	71,132	52,722	40,946
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	46,502	57,467	59,815	68,582	71,441
Total Liabilities & Shareholders' Equity	81,320	129,401	130,947	121,303	112,387
Total Common Shares Outstanding